We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+19.44%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$28.4B
AUM Growth
+$3.28B
(+13%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
22.69%
Holding
696
New
203
Increased
144
Reduced
156
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$382M |
| 2 |
JPMorgan Chase
JPM
|
+$330M |
| 3 |
Arista Networks
ANET
|
+$263M |
| 4 |
Zebra Technologies
ZBRA
|
+$217M |
| 5 |
Walt Disney
DIS
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$366M |
| 2 |
Cisco
CSCO
|
+$309M |
| 3 |
United Airlines
UAL
|
+$265M |
| 4 |
Western Digital
WDC
|
+$196M |
| 5 |
Medtronic
MDT
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Consumer Discretionary | 10.61% |
| 3 | Industrials | 10.56% |
| 4 | Healthcare | 9.33% |
| 5 | Financials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
526
DELISTED
Flushing Financial
FFIC
| $390K | ﹤0.01% |
32,814
-309,482
| -90% | -$3.73M |
|
|
SEPN
527
Septerna Inc
SEPN
$1.75B
| $370K | ﹤0.01% |
35,000
| – | – |
|
528
PTC Therapeutics
PTCT
$6.12B
| $332K | ﹤0.01% |
+6,795
| New | +$323K |
|
529
BridgeBio Pharma
BBIO
$16.5B
| $329K | ﹤0.01% |
+7,629
| New | +$277K |
|
530
Marker Therapeutics
MRKR
$18.7M
| $326K | ﹤0.01% |
213,020
-48,757
| -19% | -$62.6K |
|
531
Intuitive Surgical
ISRG
$134B
| $318K | ﹤0.01% |
585
-302,099
| -100% | -$158M |
|
|
BOLD
532
Boundless Bio
BOLD
$65M
| $303K | ﹤0.01% |
300,000
| – | – |
|
533
CAMP4 Therapeutics
CAMP
$266M
| $290K | ﹤0.01% |
200,000
| – | – |
|
534
Marvell Technology
MRVL
$196B
| $263K | ﹤0.01% |
+3,398
| New | +$212K |
|
535
Werewolf Therapeutics
HOWL
$19.3M
| $257K | ﹤0.01% |
235,705
| – | – |
|
|
ALDFU
536
Aldel Financial II Inc Units
ALDFU
| $228K | ﹤0.01% |
20,757
| – | – |
|
537
Nautilus Biotechnolgy
NAUT
$115M
| $184K | ﹤0.01% |
253,468
| – | – |
|
538
IN8bio
INAB
$9.64M
| $172K | ﹤0.01% |
82,484
+13,165
| +19% | +$53.5K |
|
|
ARTV
539
Artiva Biotherapeutics
ARTV
$551M
| $151K | ﹤0.01% |
100,000
| – | – |
|
540
Surrozen
SRZN
$301M
| $91.1K | ﹤0.01% |
10,188
| – | – |
|
541
Traws Pharma
TRAW
$8.1M
| $77.9K | ﹤0.01% |
52,630
| – | – |
|
542
Applied Optoelectronics
AAOI
$11.5B
| – | – |
-485,659
| Closed | -$7.45M |
|
543
Accenture
ACN
$108B
| – | – |
-152,087
| Closed | -$47.5M |
|
544
Adobe
ADBE
$105B
| – | – |
-464,257
| Closed | -$178M |
|
545
Automatic Data Processing
ADP
$108B
| – | – |
-61,008
| Closed | -$18.6M |
|
546
Adtran
ADTN
$616M
| – | – |
-445,264
| Closed | -$3.88M |
|
547
American International
AIG
$41.3B
| – | – |
-8,522
| Closed | -$741K |
|
548
Akebia Therapeutics
AKBA
$252M
| – | – |
-134,277
| Closed | -$258K |
|
549
Allegro MicroSystems
ALGM
$8.16B
| – | – |
-469,589
| Closed | -$11.8M |
|
550
Advanced Micro Devices
AMD
$789B
| – | – |
-58,519
| Closed | -$6.01M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2025 Portfolio in Review
As of Q2 2025, Alyeska Investment Group held 696 positions worth $28.4B, up 13% from $25.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Alyeska Investment Group's Q2 2025 filing shows 203 new, 144 increased, 156 reduced and 154 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,335,726 shares worth $412M. The largest sale was Amazon, an estimated $366M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q2 2025 buy was Alphabet (Google) Class A: 2,335,726 shares worth $412M.
- Alyeska Investment Group added most to JPMorgan Chase in Q2 2025, an estimated $330M increase.
- Alyeska Investment Group's biggest Q2 2025 reduction was Amazon, cutting an estimated $366M.
- Alyeska Investment Group fully exited Sherwin-Williams in Q2 2025, selling an estimated $188M.
- Alyeska Investment Group's ten largest holdings make up 23% of its $28.4B portfolio in Q2 2025.
- Alyeska Investment Group opened 203 new positions and closed 154 in Q2 2025.
- Alyeska Investment Group's portfolio value rose 13% quarter-over-quarter to $28.4B.
Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.